{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T13:01:30Z","timestamp":1754398890414},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"839","license":[{"start":{"date-parts":[[1995,9,1]],"date-time":"1995-09-01T00:00:00Z","timestamp":809913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1995,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Greater understanding of the underlying pathophysiology of acute myocardial infarction (AMI) has led to more aggressive management and lower mortality, both in-hospital and long term. AMI results mainly from thrombotic occlusion of the infarct-related coronary artery. The ensuing necrosis evolves over a 6-12 h period providing a time window for interventions designed to reduce eventual infarct size. The most appropriate interventions are those which restore coronary artery patency and hence myocardial blood flow as soon as possible. Occasionally, disruption of the occluding thrombus and compression of the underlying atheromatous lesion is best achieved by direct percutaneous transluminal coronary angioplasty. For the vast majority however, revascularisation by drug therapy is more appropriate. As soon as possible, all patients without contraindications should be offered oral aspirin and intravenous thrombolysis, usually with streptokinase but occasionally with tissue plasminogen activator. Patients in whom these agents are contraindicated should be considered for intravenous beta-blockade using atenolol or metoprolol to reduce myocardial demand and hence infarct size. Patients with large infarcts, impaired ventricular function, left ventricular failure or hypertension should be considered for early angiotensin-converting enzyme inhibitor therapy. Other agents may be valuable symptomatically, but have no proven role in reducing infarct size or mortality. After the first 24 h, the main aims of management are to assess the likelihood of later ischaemic events or death (risk stratification) and hence to choose appropriate long term secondary prophylaxis.<\/jats:p>","DOI":"10.1136\/pgmj.71.839.534","type":"journal-article","created":{"date-parts":[[2008,12,29]],"date-time":"2008-12-29T21:25:21Z","timestamp":1230585921000},"page":"534-541","source":"Crossref","is-referenced-by-count":8,"title":["The management of acute myocardial infarction"],"prefix":"10.1093","volume":"71","author":[{"given":"S","family":"Saltissi","sequence":"first","affiliation":[{"name":"Royal Liverpool University Hospital Trust , Prescot Street, Liverpool L7 8XP , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S S","family":"Mushahwar","sequence":"additional","affiliation":[{"name":"Royal Liverpool University Hospital Trust , Prescot Street, Liverpool L7 8XP , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1995,9,1]]},"reference":[{"key":"ref_1","first-page":"117","article-title":"Routine medical management of acute myocardial infarction: lessons from overviews of recent randomised controlled trials","volume":"82","author":"Yusuf, S.; Sleight, P.; Held, P.; MacMahon, S.","year":"1990","unstructured":"Yusuf S, Sleight P, Held P, MacMahon S. Routine medical management of acute myocardial infarction: lessons from overviews of recent randomised controlled trials. Circulation 1990; 82 (suppl II): II-117-34.","journal-title":"Circulation"},{"key":"ref_2","first-page":"397","article-title":"Gruppo Italiano per lo Studio della Streptochinasi nell 'Infarcto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction","volume":"i:","year":"1986","unstructured":"Gruppo Italiano per lo Studio della Streptochinasi nell 'Infarcto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; i: 397-401.","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/hrt.57.4.301","article-title":"Coronary thrombolysis","volume":"57","author":"DP, De Bono","year":"1987","unstructured":"De Bono DP. Coronary thrombolysis. Br Heart J 1987; 57: 301-5.","journal-title":"Br Heart J"},{"key":"ref_4","first-page":"703","article-title":"Thrombolysis in acute myocardial infarction","volume":"329","author":"Anderson, H.V.; Willerson, J.T.","year":"1994","unstructured":"Anderson HV, Willerson JT. Thrombolysis in acute myocardial infarction. N EnglJ Med 1994; 329: 703-9.","journal-title":"N EnglJ Med"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(94)91161-4","article-title":"Fibrinolytic Therapy Trialists (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients","volume":"343","year":"1994","unstructured":"Fibrinolytic Therapy Trialists (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311-22.","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/bmj.308.6931.767","article-title":"on behalf of the British Heart Foundation Working Group. Guidelines for the early management of patients with myocardial infarction","volume":"308","author":"Weston, C.F.M.; Penny, W.J.; Julian, D.G.","year":"1994","unstructured":"Weston CFM, Penny WJ, Julian DG, on behalf of the British Heart Foundation Working Group. Guidelines for the early management of patients with myocardial infarction. BMJ 1994; 308: 767-71.","journal-title":"BMJ"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/bmj.309.6965.1343","article-title":"Cardiology-I: treatment of myocardial infarction, unstable angina, and angina pectoris","volume":"309","author":"McMurray, J.; Rankin, A.","year":"1994","unstructured":"McMurray J, Rankin A. Cardiology-I: treatment of myocardial infarction, unstable angina, and angina pectoris. BMJ 1994; 309: 1343-50.","journal-title":"BMJ"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","article-title":"The GUSTO Investigators. An international randomised trial comparing four thrombolytic strategies for acute myocardial infarction","volume":"329","year":"1993","unstructured":"The GUSTO Investigators. An international randomised trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673-82.","journal-title":"N Engl J Med"},{"key":"ref_9","first-page":"312","article-title":"The management of acute myocardial infarction: guidelines and audit standards","volume":"28","author":"DP, De Bono; A, Hopkins","year":"1994","unstructured":"De Bono DP, Hopkins A. The management of acute myocardial infarction: guidelines and audit standards. JR Coll Physicians Lond 1994; 28: 312-7.","journal-title":"JR Coll Physicians Lond"},{"key":"ref_10","first-page":"111","article-title":"Streptokinase titres 1 to 4 years after intravenous streptokinase","volume":"84","author":"Elliot, J.M.; Cross, D.B.; Cederholm-Williams, S.; White, H.D.","year":"1991","unstructured":"Elliot JM, Cross DB, Cederholm-Williams S, White HD. Streptokinase titres 1 to 4 years after intravenous streptokinase. Circulation 1991; 84: 111-6.","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1056\/NEJM198902093200604","article-title":"Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombus in patients with acute transmural anterior myocardial infarction","volume":"320","author":"Turpie, A.G.G.; Robinson, J.G.; Doyle, D.J.","year":"1989","unstructured":"Turpie AGG, Robinson JG, Doyle DJ, et al. Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombus in patients with acute transmural anterior myocardial infarction. N Engl J Med 1989; 320: 352-7.","journal-title":"N Engl J Med"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJM199404073301407","article-title":"Percutaneous transluminal coronary angioplasty","volume":"330","author":"Landau, C.; Lange, R.A.; Hillis, L.D.","year":"1994","unstructured":"Landau C, Lange RA, Hillis LD. Percutaneous transluminal coronary angioplasty. N Engl J Med 1994; 330: 981-93.","journal-title":"N Engl J Med"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1056\/NEJM199209033271002","article-title":"et alon behalf of the CONSENSUS II study group. Effects of the early administration ofenalapril on mortality in patients with acute myocardial infarction. Results of the Co-operative New Scandinavian Enalapril Survival Study II (CONSENSUS II)","volume":"327","author":"Swedberg, K.; Held, P.; Kjekshus, J.","year":"1992","unstructured":"Swedberg K, Held P, Kjekshus J, et alon behalf of the CONSENSUS II study group. Effects of the early administration ofenalapril on mortality in patients with acute myocardial infarction. Results of the Co-operative New Scandinavian Enalapril Survival Study II (CONSENSUS II). N Engl J Med 1992; 327: 678-84.","journal-title":"N Engl J Med"},{"key":"ref_14","first-page":"1115","article-title":"Gruppo Italiano per lo Studio dela Sorpavivenza nell-Infarcto Miocardico. GISSI- 3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction","volume":"343","year":"1994","unstructured":"Gruppo Italiano per lo Studio dela Sorpavivenza nell-Infarcto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994; 343: 1115-22.","journal-title":"Lancet"},{"key":"ref_15","first-page":"868","article-title":"Chinese Cardiac Study Collaborative Group. Oral captopril versus placebo among 13.634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-I)","volume":"345","year":"1995","unstructured":"Chinese Cardiac Study Collaborative Group. Oral captopril versus placebo among 13.634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-I). Lancet 1995; 345: 868-87.","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJM199501123320203","article-title":"for the Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators. The effect of the angiotensin-converting enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction","volume":"332","author":"Ambrosioni, E.; Borghi, C.; Magnani, B.","year":"1995","unstructured":"Ambrosioni E, Borghi C, Magnani B, for the Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators. The effect of the angiotensin-converting enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. N Engl J Med 1995; 332: 80-5.","journal-title":"N Engl J Med"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/archinte.1993.00410030053008","article-title":"Kaplinsky E for the SPRINT study group. Early administration of nifedipine in suspected acute myocardial infarction","volume":"153","author":"Gouldbourt, U.; Behar, S.; Reicher-Reiss, H.; Zion, M.; Mandelzeig, L.","year":"1993","unstructured":"Gouldbourt U, Behar S, Reicher-Reiss H, Zion M, Mandelzeig L, Kaplinsky E for the SPRINT study group. Early administration of nifedipine in suspected acute myocardial infarction. Arch Intern Med 1993; 153: 345-53.","journal-title":"Arch Intern Med"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1136\/bmj.303.6816.1499","article-title":"Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials","volume":"303","author":"Teo, K.K.; Yusuf, S.; Collins, R.; Held, P.H.; Peto, R.","year":"1991","unstructured":"Teo KK, Yusuf S, Collins R, Held PH, Peto R. Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials. BMJ 1991; 303: 1499-1503.","journal-title":"BMJ"},{"key":"ref_19","first-page":"553","article-title":"Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester intravenous magnesium trial","volume":"339","author":"Woods, K.L.; Fletcher, S.; Roffe, C.; Haider, Y.","year":"1992","unstructured":"Woods KL, Fletcher S, Roffe C, Haider Y. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester intravenous magnesium trial (LIMIT 2). Lancet 1992; 339: 553-8.","journal-title":"Lancet"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/01.CIR.44.1.130","article-title":"Approaches to sudden death from coronary heart disease","volume":"44","author":"Lown, B.; Wolf, M.","year":"1971","unstructured":"Lown B, Wolf M. Approaches to sudden death from coronary heart disease. Circulation 1971; 44: 130.","journal-title":"Circulation"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1001\/jama.1988.03410130118036","article-title":"Effects of prophylactic lignocaine in suspected acute myocardial infarction. An overview of results from the randomised clinical trials","volume":"260","author":"MacMahon, S.; Collins, R.; Peto, R.W.V.; Yusuf, A.","year":"1988","unstructured":"MacMahon S, Collins R, Peto RWV, Yusuf A. Effects of prophylactic lignocaine in suspected acute myocardial infarction. An overview of results from the randomised clinical trials. JAMA 1988; 260: 1910-6.","journal-title":"JAMA"},{"key":"ref_22","first-page":"765","article-title":"Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment ofacute myocardial infarction","volume":"106","author":"true","year":"1983","unstructured":"Hartzler GO, Rutherford BD, McConahay DR, et al. Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment ofacute myocardial infarction. Am Heart J 1983; 106: 765-73.","journal-title":"Am Heart J"},{"key":"ref_23","first-page":"35","article-title":"Percutaneous transluminal coronary angioplasty and acute myocardial infarction","volume":"52","year":"1994","unstructured":"Grech ED, Ramsdale DR. Percutaneous transluminal coronary angioplasty and acute myocardial infarction. BrJHosp Med 1994; 52: 35-41.","journal-title":"BrJHosp Med"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199303113281001","article-title":"A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction","volume":"328","author":"Grines, C.L.; Browne, K.F.; Marco, J.","year":"1993","unstructured":"Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engi J Med 1993; 328: 673-9.","journal-title":"N Engi J Med"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/71\/839\/534\/50219202\/postgradmedj-71-534.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/71\/839\/534\/50219202\/postgradmedj-71-534.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T01:04:45Z","timestamp":1683767085000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/71\/839\/534\/7046491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,9,1]]},"references-count":24,"journal-issue":{"issue":"839","published-online":{"date-parts":[[1995,9,1]]},"published-print":{"date-parts":[[1995,9,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.71.839.534","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1995,9]]},"published":{"date-parts":[[1995,9,1]]}}}